Literature DB >> 25096666

The cardiovascular safety of azithromycin.

David N Juurlink1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25096666      PMCID： PMC4203592          DOI： 10.1503/cmaj.140572

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  Drugs and the QT interval - caveat doctor.

Authors:  Barbara A Liu; David N Juurlink
Journal:  N Engl J Med       Date:  2004-09-09       Impact factor: 91.245

2.  Azithromycin and the risk of cardiovascular death.

Authors:  Wayne A Ray; Katherine T Murray; Kathi Hall; Patrick G Arbogast; C Michael Stein
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

3.  Comparative pharmacodynamic analysis of Q-T interval prolongation induced by the macrolides clarithromycin, roxithromycin, and azithromycin in rats.

Authors:  H Ohtani; C Taninaka; E Hanada; H Kotaki; H Sato; Y Sawada; T Iga
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

4.  Cardiovascular risks with azithromycin and other antibacterial drugs.

Authors:  Andrew D Mosholder; Justin Mathew; John J Alexander; Harry Smith; Sumathi Nambiar
Journal:  N Engl J Med       Date:  2013-05-02       Impact factor: 91.245

5.  The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers.

Authors:  Alissa J Wright; Tara Gomes; Muhammad M Mamdani; John R Horn; David N Juurlink
Journal:  CMAJ       Date:  2011-01-17       Impact factor: 8.262

6.  Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.

Authors:  Peter Milberg; Lars Eckardt; Hans-Jürgen Bruns; Julia Biertz; Shahram Ramtin; Nico Reinsch; Dirk Fleischer; Paulus Kirchhof; Larissa Fabritz; Günter Breithardt; Wilhelm Haverkamp
Journal:  J Pharmacol Exp Ther       Date:  2002-10       Impact factor: 4.030

7.  Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia.

Authors:  Eric M Mortensen; Ethan A Halm; Mary Jo Pugh; Laurel A Copeland; Mark Metersky; Michael J Fine; Christopher S Johnson; Carlos A Alvarez; Christopher R Frei; Chester Good; Marcos I Restrepo; John R Downs; Antonio Anzueto
Journal:  JAMA       Date:  2014-06-04       Impact factor: 56.272

8.  Use of azithromycin and death from cardiovascular causes.

Authors:  Henrik Svanström; Björn Pasternak; Anders Hviid
Journal:  N Engl J Med       Date:  2013-05-02       Impact factor: 91.245

9.  Azithromycin for the secondary prevention of coronary artery disease: a meta-analysis.

Authors:  William L Baker; Kimberly A Couch
Journal:  Am J Health Syst Pharm       Date:  2007-04-15       Impact factor: 2.637

Review 10.  Macrolide antibiotics and the risk of cardiac arrhythmias.

Authors:  Richard K Albert; Joseph L Schuller
Journal:  Am J Respir Crit Care Med       Date:  2014-05-15       Impact factor: 21.405
  10 in total
  7 in total

Review 1.  Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.

Authors:  David N Juurlink
Journal:  CMAJ       Date:  2020-04-08       Impact factor: 8.262

Review 2.  Cardiac risks associated with antibiotics: azithromycin and levofloxacin.

Authors:  Zhiqiang Kevin Lu; Jing Yuan; Minghui Li; S Scott Sutton; Gowtham A Rao; Sony Jacob; Charles L Bennett
Journal:  Expert Opin Drug Saf       Date:  2014-12-10       Impact factor: 4.250

3.  Potential Anti-Inflammatory Treatment of Ischemic Heart Disease.

Authors:  Enisa Hodzic
Journal:  Med Arch       Date:  2018-04

4.  Safety of azithromycin in paediatrics: a systematic review protocol.

Authors:  Peipei Xu; Linan Zeng; Tao Xiong; Imti Choonara; Shamim Qazi; Lingli Zhang
Journal:  BMJ Paediatr Open       Date:  2019-06-19

Review 5.  An eye for azithromycin: review of the literature.

Authors:  Kostas A Kagkelaris; Olga E Makri; Constantine D Georgakopoulos; George D Panayiotakopoulos
Journal:  Ther Adv Ophthalmol       Date:  2018-07-30

6.  Cardiotoxicity induced by the combination therapy of chloroquine and azithromycin in human embryonic stem cell-derived cardiomyocytes.

Authors:  Ye Seul Kim; Soo Yong Lee; Jung Won Yoon; Dasol Kim; Sangbin Yu; Jeong Su Kim; Jae Ho Kim
Journal:  BMB Rep       Date:  2020-11       Impact factor: 4.778

Review 7.  Management of SARS-CoV-2 Infection: Key Focus in Macrolides Efficacy for COVID-19.

Authors:  Gaber El-Saber Batiha; Marwa A Zayed; Aya A Awad; Hazem M Shaheen; Suleiman Mustapha; Oscar Herrera-Calderon; Jorge Pamplona Pagnossa; Abdelazeem M Algammal; Muhammad Zahoor; Achyut Adhikari; Ishan Pandey; Sara T Elazab; Kannan R R Rengasamy; Natália Cruz-Martins; Helal F Hetta
Journal:  Front Med (Lausanne)       Date:  2021-04-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.